M*Modal Enhances Fluency Direct Front-End Speech Solution

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
M*Modal Enhances Fluency Direct Front-End Speech Solution for Physicians

FRANKLIN, TN--(Marketwired - Apr 13, 2015) - M*Modal, a leading provider of clinical documentation and Speech Understanding™ solutions, today announced enhancements to its Fluency Direct front-end speech software. Improvements in system customization, platform integration, speech understanding and software management can help physicians and healthcare professionals more quickly and easily create high-quality clinical documentation in electronic health record (EHR) systems.

M*Modal will be demonstrating Fluency Direct at the 2015 HIMSS conference, being held April 12-16 in Chicago (booth #2243).

Fluency Direct is cloud-based software that allows healthcare providers to verbally create and edit patient narratives directly in EHR templates. The solution leverages M*Modal's Speech Understanding and Natural Language Understanding technologies to combine highly accurate speech recognition with embedded clinical documentation improvement (CDI) capabilities.

"As hospitals continue to look for ways to improve productivity and get the most out of their EHR investment, M*Modal's Fluency Direct can play a huge role in increasing system adoption and physician satisfaction," said Scott MacKenzie, CEO of M*Modal. "With these new features, Fluency Direct offers a cost-effective, easy to use platform for creating high-quality patient records."

M*Modal's Fluency Direct software is interoperable with over 80 leading EHRs -- including Epic, Cerner, Meditech, CPSI, McKesson and Allscripts -- and was recently ranked among the top front-end speech recognition solutions by market analyst firm KLAS.

Enhancements to Fluency Direct include:

  • Better EHR integration and customization. New command capabilities to handle previously complex and variable tasks.
  • Improved efficiency. New functionality to greatly reduce the amount of time necessary to personalize and train the system.
  • Embedded CDI. Fluency Direct's Computer Assisted Physician Documentation (CAPD) is now integrated with M*Modal's CDI platform, providing real-time messaging and alerting to improve patient record accuracy.
  • Easy installation, deployment and maintenance. Further enhanced deployment flexibility and scalability to allow expanded support for application streaming, virtual desktops and thin clients.

Fluency Direct is designed from the ground up to specifically recognize healthcare terminology, execute voice-based navigation and system commands, and allow physicians to access their trained voice profiles anytime and across a variety of devices.

M*Modal's speech platform processes the documentation of more than 200,000 physicians every day, and its portfolio of clinical documentation products are supported by in-house adoption and implementation service teams.

M*Modal Fluency Direct is available now with these enhancements. Contact M*Modal at 1-866-542-7253 for discount schedules and user licensing terms.

About M*Modal
M*Modal is a leading healthcare technology provider of advanced clinical documentation solutions, enabling hospitals and physicians to enrich the content of patient electronic medical records (EMR) for improved healthcare and comprehensive billing integrity. As one of the largest clinical transcription service providers in the U.S., with a global network of medical editors, M*Modal also provides advanced cloud-based Speech Understanding™ technology and data analytics that enable physicians and clinicians to include the context of their patient narratives into electronic health records in a single step, further enhancing their productivity and the cost-saving efficiency and quality of patient care at the point of care. For more information, please visit www.mmodal.com, Twitter, Facebook and YouTube.

Media Contact:
Glen Haley
M*Modal
Email Contact
615-867-3511

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exciting New Development Partnership in Wasaga Beach Focuses on Growth

Updated Category News Views 262

New Development Partnership Announcement Sunray Group of Hotels is excited to announce a letter of intent for a new development project alongside the Town of Wasaga Beach. This venture, located at the intersection of First Street North and Beach Drive, is strategically positioned on four acres of valuable land across from Beach Area One. The proposed project consists of a...

Continue Reading
iGlobal Media USA Launches $500,000 Investment Round for Growth

Updated Category News Views 231

iGlobal Media USA Opens Investment Round for Expansion iGlobal Media USA, a leading name in digital broadcasting, is excited to announce a new opportunity for investors with a significant investment round aimed at raising $500,000. This funding will be pivotal for accelerating the national expansion of its advanced cloud-based radio platform, which promises to...

Continue Reading
STMicroelectronics Shares Update: Share Repurchase Program Details

Updated Category News Views 156

STMicroelectronics Shares Update on Repurchase Program STMicroelectronics N.V. (the "Company" or "STMicroelectronics"), a prominent name in the semiconductor industry, has actively engaged in a share repurchase program aimed at enhancing shareholder value. This program, initially revealed in a previous announcement, serves as a testament to the Company's commitment to...

Continue Reading
Chicago Mayor Brandon Johnson Set to Tackle Key Issues in D.C.

Updated Category News Views 103

Chicago Mayor Brandon Johnson to Speak at National Press Club Join us for an insightful luncheon featuring Chicago Mayor Brandon Johnson as he takes the stage at the National Press Club. This important event is set for the 28th of January, providing a platform for the Mayor to discuss pressing topics affecting residents. Event Overview The Headliners Luncheon will kick...

Continue Reading
BioCryst Pharmaceuticals Reveals HRU Improvements with ORLADEYO

Updated Category News Views 184

BioCryst Pharmaceuticals Introduces New HRU Findings BioCryst Pharmaceuticals, Inc. has recently shared compelling evidence regarding their product, ORLADEYO (berotralstat), that highlights its impact on reducing healthcare resource utilization for patients suffering from hereditary angioedema (HAE). This important finding underscores the therapy's role not only in...

Continue Reading